Minerva

Priority setting partnerships and other stories . . .

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.g7847 (Published 08 January 2015) Cite this as: BMJ 2015;350:g7847

“From the bench to the bedside” is a good motto for making money, but “from the greatest need to the best answer” is what medical research should really be about. We need a range of patients and practising clinicians to agree about what really matters in a series of priority setting partnerships (PSPs). This is exactly what the James Lind Alliance has been doing for the past 10 years, with gathering pace and increasing international recognition. The PSP on Parkinson’s disease has just reported on its top 10 priorities (BMJ Open 2014;4:e006434 doi:10.1136/bmjopen-2014-006434) for research: sleep disturbance and cognitive problems feature together with the more familiar neuromuscular symptoms.

So you think type 1 diabetes is simple—an autoimmune disease that usually starts in the first two decades of life and causes complete inability to produce insulin? Two new studies challenge the familiar paradigm. Between 2006 and 2013, paediatric diabetes …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe